Merck Current Ratio 2010-2024 | MKKGY
Current and historical current ratio for Merck (MKKGY) from 2010 to 2024. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Merck current ratio for the three months ending June 30, 2024 was 1.31.
| Merck Current Ratio Historical Data |
| Date |
Current Assets |
Current Liabilities |
Current Ratio |
| 2024-06-30 |
$14.05B |
$10.70B |
1.31 |
| 2024-03-31 |
$13.92B |
$10.79B |
1.29 |
| 2023-12-31 |
$13.41B |
$9.42B |
1.43 |
| 2023-09-30 |
$14.76B |
$9.45B |
1.56 |
| 2023-06-30 |
$14.20B |
$9.65B |
1.47 |
| 2023-03-31 |
$13.90B |
$10.26B |
1.36 |
| 2022-12-31 |
$12.86B |
$10.02B |
1.28 |
| 2022-09-30 |
$13.04B |
$9.48B |
1.38 |
| 2022-06-30 |
$13.21B |
$10.34B |
1.28 |
| 2022-03-31 |
$12.44B |
$11.45B |
1.09 |
| 2021-12-31 |
$12.99B |
$12.34B |
1.05 |
| 2021-09-30 |
$12.16B |
$11.55B |
1.05 |
| 2021-06-30 |
$12.27B |
$11.83B |
1.04 |
| 2021-03-31 |
$12.80B |
$12.84B |
1.00 |
| 2020-12-31 |
$10.60B |
$10.55B |
1.01 |
| 2020-09-30 |
$11.99B |
$11.35B |
1.06 |
| 2020-06-30 |
$10.71B |
$11.10B |
0.97 |
| 2020-03-31 |
$11.05B |
$11.88B |
0.93 |
| 2019-12-31 |
$10.08B |
$13.26B |
0.76 |
| 2019-09-30 |
$15.03B |
$10.74B |
1.40 |
| 2019-06-30 |
$13.14B |
$11.80B |
1.11 |
| 2019-03-31 |
$11.94B |
$12.71B |
0.94 |
| 2018-12-31 |
$10.91B |
$10.06B |
1.08 |
| 2018-09-30 |
$9.71B |
$10.43B |
0.93 |
| 2018-06-30 |
$9.75B |
$9.86B |
0.99 |
| 2018-03-31 |
$9.60B |
$10.49B |
0.92 |
| 2017-12-31 |
$8.43B |
$9.76B |
0.86 |
| 2017-09-30 |
$8.85B |
$9.61B |
0.92 |
| 2017-06-30 |
$8.67B |
$9.82B |
0.88 |
| 2017-03-31 |
$8.56B |
$9.94B |
0.86 |
| 2016-12-31 |
$8.49B |
$10.06B |
0.84 |
| 2016-09-30 |
$8.13B |
$9.50B |
0.86 |
| 2016-06-30 |
$8.20B |
$9.51B |
0.86 |
| 2016-03-31 |
$8.15B |
$9.97B |
0.82 |
| 2015-12-31 |
$8.16B |
$10.41B |
0.78 |
| 2015-09-30 |
$18.49B |
$5.86B |
3.15 |
| 2015-06-30 |
$15.34B |
$5.88B |
2.61 |
| 2015-03-31 |
$16.57B |
$6.00B |
2.76 |
| 2014-12-31 |
$13.93B |
$8.78B |
1.59 |
| 2014-09-30 |
$9.70B |
$7.73B |
1.26 |
| 2014-06-30 |
$8.51B |
$7.07B |
1.21 |
| 2014-03-31 |
$10.61B |
$7.01B |
1.51 |
| 2013-12-31 |
$9.81B |
$5.18B |
1.89 |
| 2013-09-30 |
$9.77B |
$5.40B |
1.81 |
| 2013-06-30 |
$9.77B |
$5.87B |
1.67 |
| 2013-03-31 |
$9.40B |
$6.10B |
1.54 |
| 2012-12-31 |
$8.52B |
$5.87B |
1.45 |
| 2012-09-30 |
$8.93B |
$6.25B |
1.43 |
| 2012-06-30 |
$8.43B |
$5.06B |
1.67 |
| 2012-03-31 |
$0.00B |
|
0.00 |
| 2011-12-31 |
$8.91B |
$6.08B |
1.47 |
| 2011-09-30 |
$0.00B |
|
0.00 |
| 2011-06-30 |
$8.75B |
$5.12B |
1.71 |
| 2011-03-31 |
$0.00B |
|
0.00 |
| 2010-12-31 |
$0.00B |
|
0.00 |
| 2010-09-30 |
$7.59B |
$4.97B |
1.53 |
| 2010-06-30 |
$0.00B |
|
0.00 |
| 2010-03-31 |
$0.00B |
|
0.00 |
| 2009-12-31 |
$0.00B |
|
0.00 |
| 2009-09-30 |
$0.00B |
|
0.00 |
| 2009-06-30 |
$0.00B |
|
0.00 |
| 2009-03-31 |
$0.00B |
|
0.00 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
MED-DRUGS |
$21.306B |
$22.719B |
|
Merck is a global pharmaceutical and chemical company. Its success is characterized by innovations from entrepreneurial employees. Merck's operating activities come under the umbrella of Merck KGaA, in which the Merck family holds an approximately 70% interest and free shareholders own the remaining approximately 30%. In 1917 the U.S. subsidiary Merck & Co. was expropriated and has been an independent company ever since.
|
